scholarly journals Double-Blind, Placebo-Controlled, Multicenter, Randomized, Phase Ii Study of Nimotuzumab in Combination with Mitomycin, 5-Fluorouracil and Radiation in Immunocompetent Patients with Anal Carcinoma

2014 ◽  
Vol 25 ◽  
pp. iv209
Author(s):  
U. Pérez González ◽  
F.F. Llorente Llano ◽  
M. Ramos Suzarte ◽  
J.E. Rodríguez Reigosa ◽  
B.F. Mestre Fernández ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Anal Carcinoma ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Randomized Phase Ii ◽  
Immunocompetent Patients

scholarly journals Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis

2014 ◽  
Vol 73 (5) ◽  
pp. 1047-1054 ◽  
Author(s):  
Toru Aoyama ◽  
Kazuhiro Nishikawa ◽  
Nobuhiro Takiguchi ◽  
Kazuaki Tanabe ◽  
Motohiro Imano ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Phase Ii ◽  
Cancer Chemotherapy ◽  
Oral Mucositis ◽  
Phase Ii Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Randomized Phase Ii

Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study

2010 ◽  
Vol 30 (2) ◽  
pp. 681-687 ◽  
Author(s):  
Katalin Boér ◽  
István Láng ◽  
Antonio Llombart-Cussac ◽  
Inger Andreasson ◽  
Guillermo L. Vivanco ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Line Treatment ◽  
Second Line ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document